OCT Angiography in Wet AMD
Oregon Health and Science University · NCT02253030
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 50–100 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 160
- US sites recruiting
- 1
- Study start
- September 2014
- Record last updated
- February 12, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The primary goals of this study are to use optical coherence tomography (OCT) angiography (blood vessel mapping) to:
- diagnose the presence of new blood vessels in wet age-related macular degeneration (AMD)
- evaluate patients undergoing treatment for wet AMD
- determine if reduced flow to the choroid is a risk factor for developing wet AMD.
Being studied: Optical Coherence Tomography
Conditions: Neovascular (Wet) Age-related Macular Degeneration (AMD)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria (Groups with wet AMD):
- Adults aged 50 and older with clinical findings of treatment-naïve (never treated) neovascular AMD with active new blood vessel growth confirmed by clinical testing will be considered
Inclusion Criteria (Group with healthy eyes)
- No evidence of retinal disease
- Refractive error greater than +3.00 diopters or -7.00 diopters (glasses Rx)
- No recent eye surgery in the last 4 months
- No significant cataract to interfere with the quality of the imaging
Exclusion Criteria (All Groups):
- Inability to give informed consent
- Significant kidney disease
- Blood pressure greater than 180/110
- Previous macular laser treatment
- Inability to maintain stable fixation during OCT imaging
- Visual acuity worse than 20/200
Recruiting US locations
Casey Eye Institute, Oregon Health & Science University
Portland, OR 97239
Site contact: George Pacheco, COA · 503-494-7398 · pachecge@ohsu.edu
Study contacts (from the official record)
- George Pacheco, COA · 503-494-7398 · pachecge@ohsu.edu
- Denny Romfh, OD · 503-494-4351 · romfhd@ohsu.edu
Similar studies in Oregon
All healthy volunteers studies in Oregon →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Bend, OR + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteersPhase 1/Phase 2
Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination
Oregon Health and Science University
- Location
- Portland, OR
- Eligibility basics
- Ages 20–49
- RecruitingHealthy volunteersEarly Phase 1
Monoferric for Prenatal Iron Deficiency
Oregon Health and Science University
- Location
- Portland, OR
- Eligibility basics
- Ages 18–65 · Women only
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Portland, OR + 55 other US sites
- Eligibility basics
- Ages 18–79